How to speak internal medicine

You know it's true #putthatcalculatoraway #gestalt

🙌 Happy to share that our @MRIdian team at @UniSpital_USZ just applied the 2222th online adaptive MRgRT fraction to provide optimal cancer care for our patients. 👏 ☢️ radonc 🧲 @MRI @fightcancer

Just published! Proud to be part of this amazing group Ane Appelt Jonas Willmann, MD Nicolaus Andratschke ESTRO and EORTC consensus on re-irradiation: definition, reporting, and decision making ESTRO EORTC #radonc #OncoAlert OncoAlert The Lancet Oncology authors.elsevier.com/c/1fpnb5EIIgH-…

🚨 just published ESTRO and EORTC consensus on re-irradiation: definition, reporting, and clinical decision making doi.org/10.1016/S1470-… The Lancet Oncology #radonc A thread 🧵 👇 1/n

ReCare is the second cohort of E2RADIatE, a platform run by EORTC and ESTRO for observational, prospective studies in radiotherapy. We are gearing up to be able to offer randomized questions on top of it. Have an idea for the 3rd or 4th cohort? project.eortc.org/e2-radiate/pla…

How would you define 're-irradiation'? Based on overlap? Cumulative risk of toxicity? Or any repeat delivery of radiation? Wonder no more! The new ESTRO EORTC consensus on re-irradiation, out today in Lancet Oncology, provides harmonised definitions #radonc #medphys

Most important and most inspiring talk of the day with a clear message to us all ‘don’t sit on the data that patients invested their lives into’ EORTC #EORTC60 #JanGeisser #patientadvocacy

Today, on our TrueBeam 1001 we produced an eFlash beam with 1Gy per pulse in the isocenter Unispital_USZ Universität Zürich. Thanks to the Varian team for a great collaboration. We are looking forward to our eFlash research program #FlashRT #FlashRadiationTherapy #medphys #radonc

The first EU-wide STAR data registry is now open! 🖥️🎉🙌Want to learn more about the project & what we hope to achieve? Watch our animation: youtube.com/watch?v=rmyJvG… #EPeeps #radiotherapy #h2020

#ESTRO23 #clinicaltrack pre-meeting course covers various aspects of #PalliativeCare with a multi & interdisciplinary perspective, discussions on #radiation planning, complex cases, reirradiation, large targets... ⏳Early fee until 22 Feb bit.ly/3vMYgzl #radonc #RTT

Jonas Willmann, MD Nicolaus Andratschke useful for our upcoming discussion with prospective ReCare investigators!

30 days to go! Join us live in Zurich Unispital_USZ on June 15: 👉Farewell Symposium for Prof. Dr. Stephan Bodis usz.ch/en/event/farew… 👉Reirradiation Symposium usz.ch/veranstaltung/… Don't forget to register for this exciting, international day Radio-Onkologie USZ Comprehensive Cancer Center Zurich !

Want to learn more about reirradiation? Then join our Symposium on 15th of June in the afternoon. Register here for in person or virtual attendance: lnkd.in/es-8QpYH And find the current program here as well: lnkd.in/exS46Cdz

(1/n) PROSPECT – important study of high quality & relevance for rectal cancer pts nejm.org/doi/full/10.10… HOWEVER, misleading & dangerous interpretation of The New York Times „brutal effects of RT“ nytimes.com/2023/06/04/hea…

The European Society for Radiotherapy and Oncology (ESTRO) issued the following statement regarding the PROSPECT clinical trial for patients with resectable rectal cancer: lnkd.in/eAKgFCru #radiotherapy #radiationoncology #radonc

"On behalf of the European radiation oncology community and our patients, ESTRO urges a return to responsible communication presenting scientific facts in a balanced manner with headlines that inform rather than alarm."

We are delighted to announce that the first site for #ReCare, a cohort of the #E2RADIatE platform, has been activated. More: project.eortc.org/e2-radiate/202… @WBA_Global, Nicolaus Andratschke, Jonas Willmann, MD, Nieder Carsten, #CancerResearch #ClinicalTrials #Oncology